Connecticut 2015 Regular Session

Connecticut House Bill HB05103 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 General Assembly Proposed Bill No. 5103
22 January Session, 2015 LCO No. 124
33 *00124*
44 Referred to Committee on PUBLIC HEALTH
55 Introduced by:
66 REP. BUCK-TAYLOR, 67th Dist.
77
88 General Assembly
99
1010 Proposed Bill No. 5103
1111
1212 January Session, 2015
1313
1414 LCO No. 124
1515
1616 *00124*
1717
1818 Referred to Committee on PUBLIC HEALTH
1919
2020 Introduced by:
2121
2222 REP. BUCK-TAYLOR, 67th Dist.
2323
2424 AN ACT CONCERNING COMPOUNDING PHARMACIES.
2525
2626 Be it enacted by the Senate and House of Representatives in General Assembly convened:
2727
2828 That the general statutes be amended to require hospital personnel to ensure that any drug manufacturer or compounding pharmacy from which the hospital procures compound pharmaceuticals is properly registered with the Commissioner of Consumer Protection or has submitted an addendum to its pharmacy license in accordance with the provisions of title 21a as required for the sale of compound drugs.
2929
3030 Statement of Purpose:
3131
3232 To verify the status of compounding pharmacies.